 interferon therapi acut posttransfus non-a non-b hepat respons respect anti-hepat viru antibodi statu effect interferon therapi posttransfus non-a non-b acut hepat appear serum hepat viru antibodi anti-hcv abnorm serum aminotransferas level onset hepat patient interferon patient eleven patient unit human fibroblast beta-interferon time wk unit human lymphoblastoid alpha-interferon daili month interferon-tr patient effect therapi hepat histolog detect anti-hcv month onset hepat common interferon-tr patient control patient vs vs NS month onset hepat anti-hcv level interferon-tr patient control patient abnorm serum aminotransferas level month onset hepat common interferon-tr patient control vs vs vs percentag abnorm serum aminotransferas level month onset hepat interferon-tr patient control patient anti-hcv-posit patient vs NS vs NS vs anti-hcv-neg patient vs NS vs NS vs NS interferon therapi histolog activ index anti-hcv-posit patient NS anti-hcv-neg patient NS biopsi specimen patient month interferon therapi normal histolog anti-hcv-posit patient anti-hcv-neg patient improv anti-hcv-posit patient result short-term low-dos interferon therapi effect posttransfus non-a non-b acut hepat anti-hcv-posit anti-hcv-neg